Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate

Star0

DB02314ExperimentalSmall molecule

Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate: Overview.

Formula / weight: C₂₈H₄₃N₅O₂₃P₂ · 879.6082 g/mol (avg)

Resolves to

Compound

ChEBI46143PubChem449538KEGGC00692

Structure

InChIKeyOJZCATPXPWFLHF-HPUCEMLMSA-NSMILES

C[C@H](NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=CC(=O)NC2=O)[C@@H]1NC(C)=O)C(=O)N[C@H](CCC(O)=O)C(O)=O

Targets

P22188murEP14900murD

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account